155 related articles for article (PubMed ID: 8958802)
1. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
[TBL] [Abstract][Full Text] [Related]
2. [Are there differences between ex adenoma and de novo colorectal carcinomas?].
Mueller J; Mueller E; Keller G; Bethke B; Stolte M; Höfler H
Verh Dtsch Ges Pathol; 1999; 83():139-47. PubMed ID: 10714204
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin, beta-catenin and stromelysin-3 expression in de novo carcinoma of the colorectum.
Włodarczyk J; Stolte M; Mueller J
Pol J Pathol; 2001; 52(3):119-24. PubMed ID: 11769398
[TBL] [Abstract][Full Text] [Related]
5. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
6. [Expression of protein p53 in the adenoma-colorectal carcinoma sequence].
Gafà R; Lanza G
Pathologica; 1998 Aug; 90(4):351-6. PubMed ID: 9793394
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
Wang DG; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
[TBL] [Abstract][Full Text] [Related]
8. Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia.
Kaklamanis L; Savage A; Mortensen N; Tsiotos P; Doussis-Anagnostopoulou I; Biddolph S; Whitehouse R; Harris AL; Gatter KC
J Pathol; 1996 May; 179(1):10-4. PubMed ID: 8691332
[TBL] [Abstract][Full Text] [Related]
9. Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis.
Mikami T; Yanagisawa N; Baba H; Koike M; Okayasu I
Cancer; 1999 Jan; 85(2):318-25. PubMed ID: 10023698
[TBL] [Abstract][Full Text] [Related]
10. p53 and bcl-2 protein expression in rectosigmoid adenomas.
Papatheodoridis GV; Kapranos N; Tzouvala M; Triantafyllou K; Elemenoglou I; Karamanolis DG
Am J Gastroenterol; 1998 Jul; 93(7):1136-40. PubMed ID: 9672345
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas.
Agui T; McConkey DJ; Tanigawa N
Anticancer Res; 2002; 22(3):1769-76. PubMed ID: 12168867
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
14. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon.
Flohil CC; Janssen PA; Bosman FT
J Pathol; 1996 Apr; 178(4):393-7. PubMed ID: 8691316
[TBL] [Abstract][Full Text] [Related]
15. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
16. Genetic pathways of 'de novo' colorectal carcinomas with reference to fetal-type glycogen phosphorylase positive foci.
Shiomori K; Shimada S; Marutsuka T; Hatayama I; Ogawa M
Int J Oncol; 2003 Jan; 22(1):65-74. PubMed ID: 12469186
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of p53, c-erbB2, CEA proteins in colorectal adenoma and carcinoma].
Shu M; Liu S; Yu P
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):129-32. PubMed ID: 10681823
[TBL] [Abstract][Full Text] [Related]
18. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
[TBL] [Abstract][Full Text] [Related]
19. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death in colorectal carcinogenesis.
Valentini AM; Caruso ML; Armentano R; Pirrelli M; Rizzi E; Lapenna F; Renna L
Anticancer Res; 1999; 19(4B):3019-24. PubMed ID: 10652586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
